  |
 |
| By turning a misfortune into a blessing, Taejoon has tried its utmost effort to achieve localization of Contrast Media for Angiography and to be the first company in Korea exporting Solotop. Now, Taejoon has become the symbol of "The First" with its rapid and strong growth. | |
| The company makes preparation for all 3 different fields of Contrast media; 'Contrast media for Upper Gastrointestinal tract' , 'Contrast Media for Angiography, and 'Contrast Media for MRI' and this, out of many other factors, makes the company unique and valuable. Based on these, Taejoon is trying to leap again for the goal of "Global Pharmaceutical Company in specialized area in 2010," "Bio Tech Company based on R&D in 2020." To achieve these goals, long term visions are being established and actualized under the company slogan, 'Company, always devoting.' We will never slow down developing to be the reliable health provider by constantly making efforts on research and we will keep our innovative and creative Entrepreneurship by consistently challenging. Again, Taejoon will fulfill the mission that it will do its best to meet customers' needs. |
|
 |
||
 |
TAEJOON PHARM Co., Ltd. |
|
 |
||
 |
April 01, 1978 |
|
|
||
 |
Lee, Tae Young |
|
|
||
 |
Head : 657-87 Hannam-dong,TAEJOON Bldg., Youngsan-gu, Seoul (140-210)
Tel : (02)798-6601~7 Fax : (02)795-8874  Plant/Lab : 704-1Book-ri, Namsa-myeon, Youngin-si, Gyeonggi-do (449-884)
Tel : (031)334-8610~2 Fax : (031)333-6756  |
|
|
||
 |
About 280 |
|
|
||
 |
Ophthalmic agents, Contrast media & Adjuvants for Radiology, ETC |
|
|
||
 |
 |
Nigeria , Sudan, Pakistan, Thailand, Singapore, Vietnam, Taiwan, Srilanka, Chile  |
 |